(NYSE: WAT) Waters's forecast annual revenue growth rate of 4.53% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.44%.
Waters's revenue in 2025 is $3,046,056,000.On average, 5 Wall Street analysts forecast WAT's revenue for 2025 to be $186,574,635,465, with the lowest WAT revenue forecast at $185,419,926,867, and the highest WAT revenue forecast at $187,584,343,282. On average, 6 Wall Street analysts forecast WAT's revenue for 2026 to be $197,727,493,131, with the lowest WAT revenue forecast at $192,858,181,200, and the highest WAT revenue forecast at $199,765,956,487.
In 2027, WAT is forecast to generate $210,531,312,066 in revenue, with the lowest revenue forecast at $207,270,461,176 and the highest revenue forecast at $213,792,222,480.